Here are four things to know:
1. The firm presently owns nearly 1.3 million Orthofix International shares for a $52.5 million total value.
2. Orthofix International shares comprise nearly 1.27 percent of Segall Bryant Hamill’s portfolio.
3. For the quarter, Orthofix shares had $0.28 earnings per share, surpassing the analyst consensus estimate by $0.07.
4. The company had revenue reaching $104.6 million for the quarter.
More articles on devices:
ArthroMeda raises nearly $2M for hip replacement sensors — 5 takeaways
Mesoblast’s Mesenchymal Precursor Cells receives key patent — 5 takeaways
DJO Global 2015 net sales hit $308M; Net loss hits $349.9M: 8 things to know
At the Becker's 23rd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference, taking place June 11-13 in Chicago, spine surgeons, orthopedic leaders and ASC executives will come together to explore minimally invasive techniques, ASC growth strategies and innovations shaping the future of outpatient spine care. Apply for complimentary registration now.
